Spinea-Medical presents a compelling case for improving Low Back Pain (LBP) diagnostics through a crowdsourced, big-data approach to medical imaging. The deck highlights a significant market opportunity, noting that LBP is the leading cause of global disability and costs the US alone $26B in diagnostics and treatment. The company leverages a strong intellectual property foundation, including a patent for the 'Assessment of Spinal Anatomy' and support from the Israeli Chief Scientist Office. Led by a team of PhDs and Professors with deep expertise in medical imaging and anatomy, Spinea-Medical…
Key takeaways
- Low Back Pain (LBP) is identified as the No. 1 cause of global disability and work absence (Slide 2).
- The US market for LBP diagnostics and treatment is valued at $26B, with $2B specifically for CT & MRI imaging (Slide 4).
- Spinea-Medical utilizes 'Crowd Sourced' medical imaging big data for comparative and objective analysis (Slide 3).
- The company holds a patent application (WO2011021181) for 'Assessment of Spinal Anatomy' and has two additional provisionals filed (Slide 6).
- Initial funding and support were provided by TNUFA - Chief Scientist Office (Israel) and founders' capital (Slide 6).
- The business model includes licensing and per-scan fees targeting hospitals, imaging centers, and OEMs (Slide 5).
- The leadership team consists of experts with PhDs and Professorships from institutions like the Sackler School of Medicine, TAU (Slide 7).
- A large clinical study has already been conducted to demonstrate proof of concept (Slide 6).
Executive Summary
Spinea-Medical is an Israeli-based medical technology company focused on revolutionizing the diagnosis of Low Back Pain (LBP). By utilizing a crowdsourced big data approach to medical imaging, they aim to provide more objective and comparative diagnostics in a market that is currently plagued by high recurrence rates and rising costs. The deck emphasizes a strong clinical and IP foundation, backed by a team of recognized experts in anatomy and radiology.
Slide 1: Title Slide
The title slide introduces Spinea-Medical with the tagline "Accurate LBP Diagnostics and Analytics (For the masses)." The logo features a stylized green spine within overlapping colored circles, suggesting a focus on integration and anatomical precision. The presentation is positioned as a solution for a widespread medical issue.
Slide 2: Effects of LBP Diagnosis Problem
This slide establishes the severity of the problem. It uses five circular icons to highlight key statistics: LBP is the "No. 1 in global disability" and "No. 1 in work absence and limitations." It notes that 25% of CT/MRI scans are related to this issue, yet there is a "40% Pain reoccurrence following treatment." Finally, it points to a significant "Burden on the economy," though it does not provide a specific dollar amount for the global burden here.
Slide 3: Comparative / Objective Analysis
Spinea-Medical introduces its solution concept: "Medical Imaging Big Data." The slide visually represents a single patient (highlighted in a green circle with a magnifying glass) being compared against a large population (represented by a grid of icons). The text states the data is "Crowd Sourced for better analysis," implying that their diagnostic accuracy comes from comparing individual scans against a vast, standardized database.
Slide 4: Current Market Trends And Numbers
This slide quantifies the opportunity. The central theme is "LBP Diagnostics." Key figures include a "$26B (US alone)" market for diagnostics and treatment, with "$2B" specifically for CT & MRI imaging. The slide highlights a trend of over-utilization without improved outcomes, noting a "CT X3 and MRI X4 increase in 20 years" and "Spinal interventions X3 in 20 years (US)." Crucially, it claims "No method considers the full spine" and mentions growing "Criticism regarding imaging usefulness."
Slide 5: Business Model
The business model is depicted as a cloud-based ecosystem. Spinea-Medical sits in the center (the cloud), connecting to four segments: End Users, Imaging Centers, Radiology departments/Hospitals, and OEM collaborations. Revenue is generated through direct payments ("$$$"), "Licensing," and a "Per Scan" fee (noted as "X$-Y$"). The slide mentions a "TAM: $B" for the US alone, though the specific billion-dollar figure is represented by a placeholder variable.
Slide 6: Clinical, IP & Technological Achievements
This slide serves as the traction and validation proof. It lists four pillars: 1) An "Initial version for 1st application" is ready. 2) Intellectual Property includes a patent application for "Assessment of Spinal Anatomy" (WO2011021181) and two provisionals. 3) Clinical validation is claimed via a "Large clinical study demonstrating proof of concept." 4) Funding history includes TNUFA (Chief Scientist Office, Israel) and founders' capital. It also notes a Horizon 2020 SME-1 submission in December 2014.
Slide 7: Team
The team slide showcases high-level academic and professional credentials. CEO Dr. Ori Hay has a PhD in medical image processing and 10 years of industry experience. CTO Prof. Israel Hershkovitz is a Professor of Anatomy at TAU with extensive research experience. Medical Director Prof. Natan Peled is a prominent radiologist and advisor to national committees. The presence of Prof. Igal Mirovski on the medical advisory board further bolsters their clinical credibility.
Slide 8: Contact Information
The final slide provides contact details for CEO Ori Hay, including a mobile number and email address. The company is identified as "Spinea Medical Ltd." based in Aviel, Israel. The tagline "Better Standing" is introduced here, reinforcing the anatomical focus of the company.
What Spinea-Medical Does Well
Spinea-Medical excels at defining a massive, underserved problem. By linking Low Back Pain to global disability rankings and specific US spending figures ($26B), they immediately establish the stakes. The use of a "Big Data" and "Crowdsourced" narrative aligns well with modern health-tech trends, suggesting a scalable software-driven solution rather than a hardware-heavy play. Furthermore, the team slide is exceptionally strong for a seed or early-stage venture, featuring individuals with deep domain expertise and institutional affiliations that provide immediate trust in the medical community.
What Is Missing from the Deck
The most glaring omission is a clear financial ask. There is no slide detailing how much capital the company is seeking, what the valuation expectations are, or how the funds will be allocated. Additionally, while the business model slide mentions "TAM: $B," it uses placeholders rather than concrete projections. There is also a lack of a competitive landscape analysis; while they mention that "no method considers the full spine," they do not name specific competitors or explain how they will defend their market share against established imaging software giants. Finally, the deck lacks a roadmap showing future milestones beyond the 2014 Horizon 2020 submission.
What a Founder Should Copy
Founders should emulate the way Spinea-Medical uses clinical and IP achievements to build a "moat" around their product. Citing specific patent numbers (Slide 6) and naming prestigious academic institutions (Slide 7) transforms a vague tech idea into a credible medical venture. The "Problem" slide (Slide 2) is also a great example of using icons and high-level stats to tell a story of systemic failure, which creates a natural opening for a disruptive solution. The clear segmentation of the business model (Slide 5) into different revenue streams (licensing vs. per-scan) is another strong element that shows a sophisticated understanding of medical procurement cycles.
Frequently asked questions
- What is the core problem Spinea-Medical is trying to solve?
- Spinea-Medical targets the inefficiencies in Low Back Pain (LBP) diagnostics. According to Slide 2, LBP is the leading cause of global disability, yet 40% of patients experience pain recurrence following treatment. Slide 4 notes that current methods fail to consider the full spine and there is growing criticism regarding the usefulness of current imaging, despite a 3x-4x increase in CT and MRI usage over 20 years.
- How does Spinea-Medical's technology work?
- The deck describes a 'Comparative / Objective' approach using 'Medical Imaging Big Data' that is 'Crowd Sourced for better analysis' (Slide 3). This suggests an algorithmic or AI-driven platform that compares individual patient scans against a massive database of spinal anatomy to provide more accurate diagnostics than traditional, isolated radiological reviews.
- What is the company's current stage and traction?
- Based on Slide 6, the company has achieved 'Proof of Concept' through a large clinical study. They have an 'Initial Version for 1st Application' and have submitted a Horizon 2020 SME-1 application as of December 2014. They have received non-dilutive funding from the Israeli Chief Scientist Office (TNUFA) and are backed by founders' capital.
- What is the proposed business model?
- Slide 5 outlines a cloud-based delivery system. Revenue streams include direct fees from end users and imaging centers, licensing agreements with radiology departments and hospitals, and 'X$-Y$ Per Scan' fees through OEM collaborations. The slide indicates a multi-billion dollar Total Addressable Market (TAM) in the US alone.
- Who are the key people behind Spinea-Medical?
- The team is highly academic and experienced. CEO Dr. Ori Hay holds a PhD in medical image processing with 10 years of industry experience. CTO Prof. Israel Hershkovitz is a Professor of Anatomy at Tel Aviv University. Medical Director Prof. Natan Peled is the Head of Radiology at Carmel Medical Center and an advisor to the National Israeli Imaging Committee (Slide 7).
